| Category:emulsifiers, surfactants   US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:   Physical Properties: 
| Appearance: | colorless to pale yellow clear viscous liquid (est) |  | Assay: | 95.00 to 100.00 |  | Food Chemicals Codex Listed: | No |  | Boiling Point: | 304.36 °C. @  760.00 mm Hg (est) |  | Flash Point: | 167.00 °F. TCC (   74.90 °C. ) (est) |  | logP (o/w): | 4.909 (est) |  | Soluble in: |  |  | water, 11.31 mg/L @ 25 °C (est) |    Organoleptic Properties: 
| Odor and/or flavor descriptions from others (if found). |    Cosmetic Information:   Suppliers:   Safety Information: 
|  |  | Hazards identification |  |  |  | Classification of the substance or mixture |  | GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |  | None found. |  | GHS Label elements, including precautionary statements |  |  |  | Pictogram |  |  |  |  | Hazard statement(s) |  | None found. |  | Precautionary statement(s) |  | None found. |  | Oral/Parenteral Toxicity: |  | intravenous-guinea pig LD50  38 mg/kg BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
KIDNEY, URETER, AND BLADDER: HEMATURIA
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
 Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 162, 1957.
 
 oral-guinea pig LD50  384 mg/kg
 PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
 Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 162, 1957.
 
 intraperitoneal-mouse LD50  160 mg/kg
 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 22, Pg. 967, 1991.
 
 intraperitoneal-mouse LD50  160 mg/kg
 Drugs in Japan Vol. -, Pg. 1300, 1995.
 
 intravenous-mouse LD50  100 mg/kg
 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 22, Pg. 967, 1991.
 
 intravenous-mouse LD50  100 mg/kg
 Toxicology and Applied Pharmacology. Vol. 7, Pg. 206, 1965.
 
 oral-mouse LD50  1170 mg/kg
 Toxicology and Applied Pharmacology. Vol. 2, Pg. 133, 1960.
 
 oral-mouse LD50  1170 mg/kg
 PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
 Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 162, 1957.
 
 oral-mouse LD50  3500 mg/kg
 American Perfumer and Cosmetics. Vol. 77, Pg. 35, 1962.
 
 oral-mouse LD50  4940 mg/kg
 American Perfumer and Cosmetics. Vol. 77, Pg. 35, 1962.
 
 intratracheal-rabbit LD50  > 15 mg/kg
 Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 78, 1976.
 
 intravenous-rabbit LD50  36 mg/kg
 KIDNEY, URETER, AND BLADDER: HEMATURIA
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
 Arzneimittel-Forschung. Drug Research. Vol. 7, Pg. 162, 1957.
 
 parenteral-rabbit LD50  > 75 mg/kg
 Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 78, 1976.
 
 intraperitoneal-rat LD50  125 mg/kg
 GASTROINTESTINAL: OTHER CHANGES
 Food and Cosmetics Toxicology. Vol. 8, Pg. 125, 1970.
 
 intravenous-rat LD50  27 mg/kg
 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 22, Pg. 967, 1991.
 
 intravenous-rat LD50  27 mg/kg
 Drugs in Japan Vol. -, Pg. 1300, 1995.
 
 intravenous-rat LD50  390 mg/kg
 Toxicology and Applied Pharmacology. Vol. 2, Pg. 133, 1960.
 
 oral-rat LD50  1000 mg/kg
 LIVER: FATTY LIVER DEGERATION
GASTROINTESTINAL: OTHER CHANGES
GASTROINTESTINAL: ULCERATION OR BLEEDING FROM STOMACH
 Food and Cosmetics Toxicology. Vol. 8, Pg. 125, 1970.
 
 oral-rat LD50  4150 mg/kg
 Toxicology and Applied Pharmacology. Vol. 2, Pg. 133, 1960.
 
 oral-rat LD50  8600 mg/kg
 Soap, Perfumery & Cosmetics. Vol. 38, Pg. 47, 1965.
 
 
 |  | Dermal Toxicity: |  | subcutaneous-mouse LD50 792 mg/kg Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 22, Pg. 967, 1991.
 
 subcutaneous-mouse LD50 792300 ug/kg
 Drugs in Japan Vol. -, Pg. 1300, 1995.
 
 subcutaneous-rat LD50 953 mg/kg
 Drugs in Japan Vol. -, Pg. 1300, 1995.
 
 subcutaneous-rat LD50 954 mg/kg
 Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 22, Pg. 967, 1991.
 
 
 |  | Inhalation Toxicity: |  | Not determined |    Safety in Use Information: 
| Category: |  | emulsifiers, surfactants |  | Recommendation for laureth-8 usage levels up to: |  |  | not for fragrance use. |  |  |  | Recommendation for laureth-8 flavor usage levels up to: |  |  | not for flavor use. |    Safety References:   References:   Other Information:   Potential Blenders and core components note  Potential Uses:   Occurrence (nature, food, other):note  Synonyms: 
|  | akypo rox RLM80V |  |  | bio-soft EC-639 |  | 2- | dodecoxyethanol (peg-8) |  | 2-[2-[2-[2-[2-[2-[2-(2- | dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol |  |  | nikkol BL-8SY |  |  | peg-8 lauryl ether |  |  | poly(oxy-1,2-ethanediyl), .alpha.-dodecyl-.omega.-hydroxy- (8 mol EO average molar ratio) |  |  | polyethylene glycol (8) lauryl ether |  |  | polyethylene glycol (8) monolauryl ether |  |  | polyoxyethylene (8) lauryl ether |  |  | polyoxyethylene (8) monolauryl ether |    Articles:  |